A Phase I, Double-blind, Randomised, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Multiple Dosages of Estetrol in Healthy Men
Phase of Trial: Phase I
Latest Information Update: 13 Feb 2017
At a glance
- Drugs Estetrol (Primary)
- Indications Migraine; Osteoarthritis; Prostate cancer; Vasomotor symptoms
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Pantarhei Bioscience
- 10 Jun 2017 Biomarkers information updated
- 08 Feb 2017 Status changed from active, no longer recruiting to completed.
- 23 Jan 2017 Status changed from recruiting to active, no longer recruiting.